Cornercap Investment Counsel Inc Relay Therapeutics, Inc. Transaction History
Cornercap Investment Counsel Inc
- $637 Million
- Q1 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 23,088 shares of RLAY stock, worth $144,761. This represents 0.03% of its overall portfolio holdings.
Number of Shares
23,088
Previous 23,088
-0.0%
Holding current value
$144,761
Previous $254,000
24.8%
% of portfolio
0.03%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
188Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$175 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$74.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$61.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$46.5 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$43.1 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $754M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...